p.24.0044322

proceeding

App_44322/2024

App_44322/2024 - Application to amend a patent

2023

Düsseldorf Local Division - First Instance

Date of Filing: 31/07/24

Registry Numbers: App_44322/2024

Case Title:

Patents

EP3536712

Patents

EP3536712

METHODS FOR REDUCING LIPOPROTEIN(A) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)

Parties

Applicant 1. Regeneron Pharmaceuticals Inc.

Defendant 2. Amgen S.A.S.

Defendant 3. Amgen B.V.

Defendant 4. Amgen S.R.L.

Defendant 5. Amgen GmbH

Defendant 6. Amgen Europe B.V.

Defendant 7. Amgen NV

Defendant 8. Amgen Inc.